In contrast, mast cells from well differentiated systemic mastocytosis cases show normal expression of activation markers, lack of both CD25 and CD2, a phenotype similar to that of mature resting mast cells and high expression of CD117 and FcRIe, as the main features. Here, CD2 is linked to systemic mastocytosis.